Safety issues and harmful pharmacological interactions of nutritional supplements in Duchenne muscular dystrophy: considerations for Standard of Care and emerging virus outbreaks

Por Boccanegra, Brigida, Verhaart, Ingrid E.C., Cappellari, Ornella, Vroom, Elizabeth, De Luca, Annamaria
Publicado no Pharmacol Res (2020)

Prednisolone Treatment Does Not Interfere with 2′-O-Methyl Phosphorothioate Antisense-Mediated Exon Skipping in Duchenne Muscular Dystrophy

Por Verhaart, Ingrid E.C., Heemskerk, Hans, Karnaoukh, Tatyana G., Kolfschoten, Ingrid G.M., Vroon, Anne, van Ommen, Gert-Jan B., van Deutekom, Judith C.T., Aartsma-Rus, Annemieke
Publicado em 2012

A 3-base pair deletion, c.9711_9713del, in DMD results in intellectual disability without muscular dystrophy

Por de Brouwer, Arjan PM, Nabuurs, Sander B, Verhaart, Ingrid EC, Oudakker, Astrid R, Hordijk, Roel, Yntema, Helger G, Hordijk-Hos, Jannet M, Voesenek, Krysta, de Vries, Bert BA, van Essen, Ton, Chen, Wei, Hu, Hao, Chelly, Jamel, den Dunnen, Johan T, Kalscheuer, Vera M, Aartsma-Rus, Annemieke M, Hamel, Ben CJ, van Bokhoven, Hans, Kleefstra, Tjitske
Publicado em 2014